Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Pathology West China Hospital Sichuan University Chengdu 610041 China;
Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Breast cancer; molecular subtype; CD133; drug resistant gene; chemosensitivity;